Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 174

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)

Open access
Diamanti‐Kandarakis, Evanthia, Katsikis, Ilias, Piperi, Christina, Kandaraki, Eleni, Piouka, Athanasia, Papavassiliou, Athanasios G., Panidis, Dimitrios·2008·Clinical Endocrinology

Abstract

Summary: Background Nonenzymatic advanced glycation and oxidation end‐products, advanced glycation end‐products (AGEs), impart a potent impact on vessels and other tissues in diabetic state and in euglycaemic conditions with increased oxidative stress. Insulin resistant (IR) polycystic ovary syndrome (PCOS) women, have elevated serum AGEs, increased receptor (RAGE) expression, and increased deposition with differential localization in the polycystic ovarian tissue (theca and granulosa) compared to normal. Objective To determine whether the raised AGE levels in noninsulin resistant women with PCOS is a distinct finding compared with those presenting the isolated components of the syndrome and among PCOS subphenotypes. Noninsulin resistant women were selected in order to show that serum AGEs are elevated in PCOS independently of the presence of IR. Design Clinical trial. Patients One hundred and ninety‐three age‐ and BMI‐matched young lean noninsulin resistant women were studied. Among them, 100 women were diagnosed with PCOS according to Rotterdam criteria, and divided to subphenotypes (hyperandrogenaemia with or without PCO morphology and with or without anovulation). Sixty‐eight women with the isolated components of the PCOS phenotype were also studied along with 25 healthy women. Measurements Serum AGE levels, metabolic, hormonal profiles and intravaginal ultrasound were determined in all subjects. Results The studied population did not differ in BMI, fasting insulin concentration, waist : hip and glucose : insulin ratios. PCOS women exhibited statistically higher AGEs levels (7·96 ± 1·87 U/ml, P < 0·001) compared with those with isolated hyperandrogenaemia (5·61 ± 0·61 U/ml), anovulation (5·53 ± 1·06 U/ml), US‐PCO morphology (5·26 ± 0·25 U/ml) and controls (5·86 ± 0·89 U/ml). Conclusions In PCOS, serum AGEs are distinctly elevated compared with women having the isolated characteristics of the syndrome. No difference was observed between PCOS subphenotypes. As chronic inflammation and increased oxidant stress have been incriminated in the pathophysiology of PCOS, the role of AGEs as inflammatory and oxidant mediators, may be linked with the metabolic and reproductive abnormalities of the syndrome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2008.03247.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 34

  1. 10.1210/jcem.84.11.6148 · DOI · Paper page
  2. 10.1016/S1043-2760(96)00125-7 · DOI
  3. 10.1016/S0889-8529(05)70075-X · DOI
  4. 10.2337/diab.38.9.1165 · DOI · Paper page
  5. 10.1210/er.18.6.774 · DOI · Paper page
  6. 10.1111/j.1365-2265.1992.tb02295.x · DOI · Paper page
  7. 10.1016/j.tem.2007.07.004 · DOI · Paper page
  8. 10.1161/01.ATV.15.7.821 · DOI · Paper page
  9. 10.1055/s-2007-1016308 · DOI
  10. 10.3109/00016349209006227 · DOI · Paper page
  11. Vlassara H., 1994, Recent progress on the biologic and clinical significance of advanced glycosylation end products, Journal of Laboratory Clinical Medicine, 124, 19
  12. 10.1038/ki.1995.322 · DOI
  13. 10.1172/JCI116482 · DOI · Paper page
  14. 10.1073/pnas.94.25.13915 · DOI · Paper page
  15. 10.1016/S0272-6386(03)00779-0 · DOI · Paper page
  16. 10.1093/jb/mvh193 · DOI
  17. 10.2337/diab.40.4.405 · DOI · Paper page
  18. 10.2165/00002512-199609020-00001 · DOI · Paper page
  19. 10.1074/jbc.M301088200 · DOI
  20. 10.1254/jphs.CPJ04005X · DOI
  21. 10.1161/hc0702.104183 · DOI · Paper page
  22. 10.1074/jbc.273.15.8630 · DOI
  23. 10.1111/j.1365-2265.2004.02170.x · DOI · Paper page
  24. 10.1210/jc.2003-031205 · DOI · Paper page
  25. 10.1210/jc.2004-2279 · DOI · Paper page
  26. 10.1210/jc.2004-0628 · DOI · Paper page
  27. 10.2337/dc06-0531 · DOI · Paper page
  28. 10.1007/s00418-006-0265-3 · DOI · Paper page
  29. 10.1007/s00109-007-0246-6 · DOI
  30. 10.1021/bi00046a020 · DOI
  31. 10.1172/JCI119599 · DOI
  32. 10.1042/bj2450243 · DOI · Paper page
  33. 10.1210/jc.2005-1696 · DOI · Paper page
  34. 10.1016/S0015-0282(03)00571-5 · DOI · Paper page

Cited by

See all 174

Metadata

Authors
Diamanti‐Kandarakis, E., Katsikis, I., Piperi, C., Kandaraki, E., Piouka, A., Papavassiliou, A. G., & Panidis, D.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2008-09-10
Volume
69
Issue
4
Pages
634-641
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2069811052
Cited by
174
References
7
FWCI
9.51
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). https://app.cochat.ai/papers/10.1111/j.1365-2265.2008.03247.x
The paper
Diamanti‐Kandarakis, E., Katsikis, I., Piperi, C., Kandaraki, E., Piouka, A., Papavassiliou, A. G., & Panidis, D. (2008). Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS). Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2008.03247.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.